Analysis of Donor-site Complications after Conjunctivo-limbal Autograft to Treat Pterygium. |
Min Gu Huh, Dae Jin Park |
Department of Ophthalmology, Daegu Fatima Hospital, Daegu, Korea. dj_oph_2540@hanmail.net |
군날개 치료를 위한 자가윤부결막이식술 후 공여 부위의 합병증 분석 |
허민구⋅박대진 |
대구파티마병원 안과 |
Correspondence:
Dae Jin Park, Email: dj_oph_2540@hanmail.net |
Received: 7 June 2018 • Revised: 2 August 2018 • Accepted: 18 January 2019 |
Abstract |
PURPOSE To evaluate the types, frequency, and causes of complications at the donor site after conjunctivo-limbal autograft for primary or recurrent pterygium treatment. METHODS: From January 2010 to December 2016, 91 eyes of 91 patients (male, n = 37; female, n = 54; mean age, 53.29 ± 10.73 years), diagnosed with primary or recurrent pterygium, and who were followed up for 6 months or longer after conjunctivo-limbal autograft, were enrolled in this study retrospectively. RESULTS: Of the 91 eyes, 27 eyes (29.7%) developed a conjunctival scar on the donor site and 36 eyes (39.6%) had localized vascularization. Eighteen eyes (19.8%) had a conjunctival scar and localized vascularization. Conjunctival granuloma and limbal stem cell deficiency occurred in one eye (1.1%). Multiple regression analysis showed that having a conjunctival scar and localized vascularization were significantly correlated with young age (p < 0.001), but were not significantly correlated with gender, pterygium type, dry eye, conjunctivochalasis, hypertension, diabetes, anticoagulant treatment, graft size, or delayed epithelial-wound healing. CONCLUSIONS: Conjunctival scarring or localized vascularization on the donor site after conjunctivo-limbal autograft for the treatment of the pterygium was found to be significantly higher in younger patients. Therefore, it is recommended that conjunctivo-limbal autograft should be adequately explained for donor-site complications in younger-aged pterygium patients. |
Key Words:
Complication;Conjunctivo-limbal autograft;Donor site;Pterygium |
|